Publications & Works

Publication Network
Articles 19
All (19)
SCI-E, SSCI, AHCI (10)
SCI-E, SSCI, AHCI, ESCI (12)
ESCI (2)
Scopus (16)
TRDizin (6)
Other Publications (1)

1. INCREASING THE SOLUBILITY PROPERTIES OF TETRABENAZINE AT BASIC MEDIUM BY USING SOLID DISPERSION TECHNOLOGY TETRABENAZİNİN BAZİK ORTAMDAKİ ÇÖZÜNME ÖZELLİKLERİNİN KATI DİSPERSİYON TEKNOLOJİSİ İLE ARTIRILMASI

Baş H., YERLİKAYA F., Acartürk F.
Ankara Universitesi Eczacilik Fakultesi Dergisi , vol.49, no.2, pp.241-263, 2025 (Scopus, TRDizin)

2. A Novel Method for Development and Validation of the Degradation Products Analysis of N-Carbamylglutamate with UHPLC by Using Design of Experiment Approach

Arabaci B., YERLİKAYA F., BAŞCI AKDUMAN N. E.
ACS Omega , vol.9, no.39, pp.40346-40357, 2024 (SCI-Expanded, Scopus)

3. Determination of Caffeine in Human Plasma by Using Liquid Chromatography-Tandem Mass Spectrometry

YERLİKAYA F., SAĞLAM O.
Cumhuriyet Science Journal , vol.44, no.3, pp.485-490, 2023 (TRDizin) Creative Commons License

4. The Bioequivalence Study of Two Dexketoprofen 25 mg Film-Coated Tablet Formulations in Healthy Males Under Fasting Conditions

YERLİKAYA F., Arslan A., Baş H., Sağlam O., Aytaç S. P.
Turkish Journal of Pharmaceutical Sciences , vol.20, no.2, pp.115-120, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

5. The Relative Bioavailability Study of Two Cefdinir Formulations in Healthy Males Under Fasting Conditions

YERLİKAYA F., ARSLAN A., Atik O., Kozan S., Parlak A., Özel Karataş M., et al.
FABAD Journal of Pharmaceutical Sciences , vol.48, no.1, pp.25-36, 2023 (Scopus, TRDizin)

6. The Bioequivalence Study of Two Cefdinir 250 mg/5 mL Oral Suspension Formulations in Healthy Males Under Fasting Conditions

YERLİKAYA F., Arslan A., Atik Ö., Kozan S., Parlak A., Özel Karataş M., et al.
Hacettepe University Journal of the Faculty of Pharmacy , vol.43, no.1, pp.43-49, 2023 (Scopus) Creative Commons License

7. APPLICATION OF PLACKETT-BURMAN DESIGN FOR DEVELOPMENT AND EVALUATION OF A BETAMETHASONE SUSPENSION FOR INJECTION FORMULATION BİR BETAMETAZON ENJEKSİYONLUK SÜSPANSİYON FORMÜLASYONUNUN GELİŞTİRİLMESİ VE DEĞERLENDİRİLMESİ İÇİN PLACKETT-BURMAN TASARIMININ UYGULANMASI

YERLİKAYA F., Arslan A., Arabaci B., Gençer P., NEMUTLU E.
Ankara Universitesi Eczacilik Fakultesi Dergisi , vol.47, no.2, pp.477-489, 2023 (Scopus, TRDizin)

8. A novel bedtime pulsatile-release caffeine formula ameliorates sleep inertia symptoms immediately upon awakening

Dornbierer D. A., Yerlikaya F., Wespi R., Boxler M. I., Voegel C. D., Schnider L., et al.
SCIENTIFIC REPORTS , vol.11, no.1, 2021 (SCI-Expanded, Scopus) Creative Commons License

9. Formation of quantum water in nanoparticulate systems

Yerlikaya F., Camlik G., AKKOL E., Degim Z., DEĞİM İ. T., Sobarzo-Sanchez E.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.63, 2021 (SCI-Expanded, Scopus)

10. Development of paclitaxel and flurbiprofen co-loaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett-Burman design

Sahin A., Caban-Toktas S., Tonbul H., Yerlikaya F., AKTAŞ Y., ÇAPAN Y.
ISTANBUL JOURNAL OF PHARMACY , vol.49, no.3, pp.161-166, 2019 (ESCI, TRDizin) Sustainable Development

11. Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles

Kozlu S., Sahin A., Ultav G., Yerlikaya F., ÇALIŞ S., ÇAPAN Y.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.45, pp.213-219, 2018 (SCI-Expanded, Scopus) Sustainable Development

12. Development and validation of a stability-indicating ultra-performance liquid chromatography (UPLC) method for doxycycline hyclate: An optimization of the analytical methodology for a medical countermeasure (MCM) drug

Mohammad A., Yen C. H., Schneider M., Lowry B., YERLİKAYA F., Whitesell G., et al.
Analytical Methods , vol.10, no.16, pp.1842-1851, 2018 (SCI-Expanded, Scopus)

13. A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery

ŞAHİN A., ESENDAĞLI G., YERLİKAYA F., Caban-Toktas S., Yoyen-Ermis D., HORZUM U., et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY , vol.45, no.8, pp.1657-1664, 2017 (SCI-Expanded, Scopus)

14. A Comparative Evaluation of Polystyrene Divinylbenzene Copolymer HPLC Columns on the Chromatographic Performance of the Compendial Method for Doxycycline Hyclate Capsules: Implications for Method Implementation of a Medical Countermeasure Medication

YERLİKAYA F., Mohammad A., Faustino P., Khan M. A., Saeed K.
Journal of Analytical Sciences, Methods and Instrumentation , vol.5, no.3, pp.23-34, 2015 (Peer-Reviewed Journal)

15. Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments

Xu X., Al-Ghabeish M., Rahman Z., Krishnaiah Y. S., YERLİKAYA F., Yang Y., et al.
International Journal of Pharmaceutics , vol.493, no.1-2, pp.412-425, 2015 (SCI-Expanded, Scopus)

16. Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach

Yerlikaya F., Ozgen A., VURAL İ., Guven O., Karaagaoglu E., Khan M. A., et al.
JOURNAL OF PHARMACEUTICAL SCIENCES , vol.102, no.10, pp.3748-3761, 2013 (SCI-Expanded, Scopus)

17. Formulation and In Vitro Evaluation of Paclitaxel Loaded Nanoparticles

Aygul G., YERLİKAYA F., CabanToktas S., Vural I., Capan Y.
Hacettepe University Journal of the Faculty of Pharmacy , vol.33, no.1, pp.25-40, 2013 (Scopus)

18. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles

ÖZTÜRK K., Caban S., Kozlu S., Kadayifci E., YERLİKAYA F., ÇAPAN Y.
Pharmazie , vol.65, no.9, pp.665-669, 2010 (SCI-Expanded, Scopus)

19. LC-UV Determination of Melatonin from Chitosan Nanoparticles

Yerlikaya F., Aktas Y., ÇAPAN Y.
CHROMATOGRAPHIA , vol.71, pp.967-970, 2010 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences 8

1. Comparing Intracellular Delivery of PLGA and Chitosan Nanoparticles Lessons and Challenges

ŞAHİN A., Yerlikaya F., AKTAŞ Y., ESENDAĞLI G., ÇAPAN Y.
GPEN 2016, 9 - 12 November 2016

2. Comparing Intracellular Delivery of PLGA and Chitosan Nanoparticles: Lessons and Challenges

ŞAHİN A., YERLİKAYA F., AKTAŞ Y., ESENDAĞLI G., ÇAPAN Y.
GPEN 2016, Kansas, United States Of America, 9 - 12 November 2016

3. Co Encapsulation Studies of Doxorubicin and Celecoxib in PLGA Nanoparticles

Kozlu S., ŞAHİN A., Sevda Ş., Yerlikaya F., ÇAPAN Y.
18th International Pharmaceutical Technology Symposium-IPTS 2016, 18 September 2916 - 21 September 2016

4. Intracellular delivery and intraperıtoneal retention of different sized PLGA nanoparticles prepared by nanoprecipitation method

ŞAHİN A., ESENDAĞLI G., YERLİKAYA F., KOZLU S., YÖYEN ERMİŞ D., Horzum U., et al.
18th International Pharmaceutical Technology Symposium-IPTS 2016, 18 September 2016, (Summary Text)

5. Co-Encapsulation Studies of Doxorubicin andCelecoxib in PLGA Nanoparticles

KOZLU S., ŞAHİN A., Şahan S., YERLİKAYA F., ÇAPAN Y.
18th International Pharmaceutical Technology Symposium-IPTS 2016, 18 September 2016, (Summary Text)

6. Determination of Critical Parameters of Paclitaxel and Flurbiprofen Co Loaded PLGA Nanoparticles Prepared By Nanoprecipitation

ŞAHİN A., Çaban S., Abdykerim Kyzy G., Yerlikaya F., AKTAŞ Y., ÇAPAN Y.
AAPS Annual Meeting 2015, 25 - 29 October 2015

7. Determination of Critical Parameters of Paclitaxel and Flurbiprofen Co-Loaded PLGA Nanoparticles Prepared by Nanoprecipitation

ŞAHİN A., TOKTAŞ S., Abdykerim Kyzy G., YERLİKAYA F., AKTAŞ Y., ÇAPAN Y.
American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition 2015, 25 - 29 October 2015, (Summary Text)

8. Formulation and In Vitro Evaluation of Nanoparticles Containing Docetaxel

Babat D., TOKTAŞ S., ŞAHİN A., YERLİKAYA F., VURAL İ., ÇAPAN Y.
American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition 2014, 02 November 2014, (Summary Text)
Metrics

Publication

28

Publication (WoS)

12

Publication (Scopus)

16

Citation (WoS)

109

H-Index (WoS)

5

Citation (Scopus)

321

H-Index (Scopus)

9

Citation (Sum Other)

6

Project

10

Intellectual Property

6

Thesis Advisory

2

Open Access

5
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING